Customize your JAMA Network experience by selecting one or more topics from the list below.
Jarrard DF. Does Zinc Supplementation Increase the Risk of Prostate Cancer? Arch Ophthalmol. 2005;123(1):102–103. doi:10.1001/archopht.123.1.102
In the United States, prostate cancer is the most commonly diagnosed cancer in men and the second leading cause of cancer deaths in this population. It is estimated that 220 000 cases of prostate cancer will be diagnosed this year, and this is expected to increase with the expanding geriatric population. The etiology of prostate cancer is multifactorial. Genetic factors are important and contribute to incidence rates that are higher in African Americans than any other racial group. It is also clear that diet plays an important role in modulating the cancer phenotype. There is expanding interest, both in the lay press and the scientific community, in the use of dietary supplements that minimize the initiation and progression of prostate cancer.
Create a personal account or sign in to: